Canadian Warrants Only Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian Warrants Only

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: calgarylady	4/6/2021 1:27:22 AM
	of 23102

Kalytera changes name to Claritas, to focus on R-107 2021-04-05 01:16 MT - News Release Kalytera Therapeutics Inc. has changed its name to Claritas Pharmaceuticals Inc. The decision to rename the company signals the relaunch of the company and its intent to focus on the development of its proprietary drug, R-107, for the treatment of vaccine-resistant strains of COVID-19, as well as other viral infections. R-107 is a nitric-oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection, as well as the viruses that cause influenza and the common cold. The company's ticker symbol will change as a result of the name change. The new ticker symbol will be CLAS, pending final approval of the TSX Venture Exchange, which is anticipated early next week. The company's new Cusip and ISIN numbers for the company's active listed securities under its new name are the following. Common shares: ISIN: CA1806341071 and Cusip: 180634107 Warrants designated as WT: ISIN: CA1806341154 and Cusip: 180634115 Warrants designated as WTS22: ISIN: CA1806341238 and Cusip: 180634123 stockwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next